0

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Surgery
Original Article  | 
Protective Effects of Tranexamic Acid on Clopidogrel Before Coronary Artery Bypass Grafting:  A Multicenter Randomized Trial
Jia Shi, MD; Hongwen Ji, MD; Facheng Ren, MD; et al.
JAMA Surgery
Invited Critique  | 
Balancing Thrombotic and Bleeding Risks Related to Antiplatelet Therapy in Coronary Bypass Surgery:  Comment on “Protective Effects of Tranexamic Acid on Clopidogrel Before Coronary Artery Bypass Grafting”
Nauder Faraday, MD, MPH
JAMA Internal Medicine
Editor's Correspondence  | 
Jehovah's Witnesses May Not Have Identical Outcomes With Nontransfused Non-Witnesses After Cardiac Surgery
Dimitrios C. Angouras, MD
JAMA Internal Medicine
Editor's Correspondence  | 
Jehovah's Witnesses May Not Have Identical Outcomes With Nontransfused Non-Witnesses After Cardiac Surgery—Reply
Gregory Pattakos, MD, MS; Colleen G. Koch, MD, MS, MBA; Eugene H. Blackstone, MD